QualityStocks.net "Top Movers and Shakers" for 12/10/2007

QualityStocks.net would like to highlight Bellhaven Copper & Gold, Inc. (BHV.TO) as "One To Watch" at $0.73 with 32,944 shares traded. Bellhaven Copper & Gold, Inc. a Panama-based mineral exploration company, along with its joint venture partner Dominion Minerals Corp. announced this month the completed its copper, gold and silver assay results, on the Cerro Chorcha porphyry copper project in the western highlands of Panama.

Again today QualityStocks.net would like to highlight China Organic Agriculture, Inc. (CNOA) as "One to Watch." We first highlighted (CNOA) in the $1.75 to $2.10 range. (CNOA) shares have continued to surge this month opening today at $3.90 up 5% at $4.13 with 443,049 (CNOA) was highlighted by Stock Stars, Knobias, HotStocksRus, AheadoftheBulls, Shazam Stocks, Wall Street Savant, AheadoftheBulls, Wall Street Grapevine, Boon Market, Micro Cap Money, Small Cap Voice, Stock Up Ticks, Triple Crown Stocks, and Vigilant Trader.

This month QualityStocks.net highlighted Omninet Media.com, Inc. (ONMC) as "One To Watch" at $0.03. ONMC opened today at 0.067 up 13% at $0.076 with 5,659,962 shares traded. ONMC was highlighted by OTC Stock Exchange, HotOTC.com, OTC Picks, StockEgg.com, Knobias, StockEgg.com, Penny Stock Finder Blog, Knobias, Eric David and Sons., and Micro-Cap Opportunity.

Nuvelo, Inc. (NUVO), previously at $2.12 up 21% at $2.58 with 4,239,586 shares traded, was highlighted by Stock Egg.com, OTC Picks, StockEgg.com, Subway. Nuvelo, Inc. saw increased volume to start this month, on anticipated news regarding Nuvelo Phase study which focused on the Opening of Non-functional and Occluded catheters with Mini-dose Alfimeprase-2. Investors took attention this Sunday after Nuvelo announced it was successful in demonstrating that alfimeprase, the company's lead product candidate, which was shown to actively restore catheter function and was well-tolerated in patients with catheter occlusion.

Jamba, Inc. (JMBA), previously at $4.48 up 18% at $5.30 with 3,996,238 shares traded, was highlighted by Hot OTC.com, Knobias, and StockEgg.com. Jamba, Inc. shares have surged 47% on this month's news that the company has entered into an agreement to develop juices and smoothies with Nestle SA. The deal also allows Jamba Juice to market a variety of Jamba related foods which will be sold in grocery store locations, giving consumers a new way to enjoy Jamba Juice, as well as expanding the company's market reach by encouraging brand loyalty, in not only the companies in- store locations, but now in the grocery isle as well.

Tamm Oil and Gas Corp. (TAMO) closed today at $2.55 with 29,416 shares traded. Tamm Oil and Gas Corp announced a Share Exchange Agreement with Shareholders of Deep Well Oil & Gas, Inc. The new agreement could potentially benefit both companies, through a deal which allows Tamm will acquire 31,800,000 shares of Deep Well, in exchange for 31,800,000 shares of Tamm Oil and Gas, with both companies canceling a set number of common shares, bringing Tamm's issued and outstanding shares to 85,300,000 shares post exchange, giving Tamm a majority interest in the project containing an estimated 819.5 million initial barrels of oil.

DOR BioPharma, Inc. (DORB), previously at $0.17 up 10% $0.19 with 774,894 shares traded, was recently highlighted by Stock Stars, Hot Stock Chat, OTC Picks, Knobias, and StockEgg.com. DOR BioPharma, Inc. announced last month it had signed a Letter of Intent with Orphan Australia Pty Ltd., who will act as DOR's Sponsor in the administration of a Named Patient Access Program (NPAP) for orBec® to gastrointestinal Graft-versus-Host disease (GI GVHD) patients in Australia, New Zealand and South Africa. This presents an interesting story in part because of the sharp contrasts between Australia, New Zealand and South Africa's stance on unproven, but possibly helpful specialty pharmaceutical's versus the American Medical systems and their reluctance to supply patients with access to not yet approved medicines for seriously ill patients.

Creative Vistas, Inc. (CVAS), previously at $1.75 up 5% at $1.85 with 55,077 shares traded, was highlighted today by Wall Street Savant and recently by HotStix. Creative Vistas, Inc. announced this month it has received approval for research funding from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP). Subject to the terms of the agreement, Creative Vistas will receive funding in support of research and development activities in Business Intelligence (BI) software.

QualityStocks.net would like to welcome one of our newest clients, ECOtality (ETLY). ECOtality continues to strengthen its postition in the electric power cell technology sector, through it's continued focus on company acquisitions. The company announced this week the execution of a definitive agreement to purchase all assets and business of Minit-Charger, a subsidiary of Edison International, a NYSE-listed company, for $3 million in cash and stock. The combination of recently acquired companies will provide ECOtality with a revenue base of companies whose combined trailing twelve month revenues are $14.55 million for the period ending third quarter of 2007.

QualityStocks.net would like to highlight our newest client, NavStar Technologies, Inc. (NVST). NavStar Technologies, Inc. announced exciting details on in new affordably priced Voice Navigator ™ navigation device, which offers a feature-rich alternative to expensive GPS navigation devices currently available. The new hands free device is compact, simple and safe to use, feature rich. The Voice Navigator ™ allows the user to request and download a route or make a hands-free call with their voice rather that the cumbersome input required when inputting via a screen. The Voice Navigator is the only product currently available that can receive requests for direction by voice. NavStar's proprietary voice direction database provides users with higher quality verbal directions compared to competing products while at the same time staying considerably lower priced.

QualityStocks.net would like to highlight Voiceserve, Inc. (VSRV), previously at $0.65 up 15% at $0.75 with 2,300 shares traded. Voiceserve, Inc. shares were boosted on news that the company has been rated Speculative Buy with a price target of $1.65 by Beacon Equity Research Analyst, Victor Sula, PhD. The full report is available at http://www.BeaconEquityResearch.com

QualityStocks.net would also like to highlight another new client, Pressure BioSciences Inc. (PBIO) as "One To Watch." Pressure BioSciences Inc. is a life sciences company, we have followed for much of this year, through our relationship with the Red Chip Conferences. Pressure BioSciences Inc. continues to make advancements regarding its pressure cycling technology (PCT). Frost & Sullivan announced that Pressure BioSciences, Inc. has been named the recipient of the 2007 North American Frost & Sullivan Award for Technology Innovation. The award is in recognition of the development and advancements regarding the combination of the Company's Pressure Cycling Technology (PCT) with the innovative chemistry of its ProteoSolve-LRS kit.

About QualityStocks

QualityStocks.net, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks.net is dedicated to assisting emerging public companies with their advertising efforts and now has over 300,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

“Please see the disclaimers on the QualityStocks.net website”